EE571 Cost-Effectiveness of Maribavir for Post-Transplant Refractory Cytomegalovirus Infection With or Without Resistan A UK Perspective
Abstract
Authors
E Chowdhury T de Lacey R Ressa JE Poirrier P Cain E Fenu SL Amorosi